A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkB binding site: Evidence for a role of NFkB in ischemia-reperfusion injury

Circulation

Volumn 96, Issue 9 SUPPL., 1997, Pages

  Sawa, Yoshiki ^a   Morishita, Ryuichi ^a   Suzuki, Ken ^a   Kagisaki, Koji ^a   Kaneda, Yasufumi ^a   Maeda, Kazuhiro ^a   Kadoba, Keishi ^a   Matsuda, Hikaru ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Genes; Ischemia; Leukocytes; Molecular biology; Reperfusion

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; ISOTHIOCYANIC ACID; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LEUKOCYTE ADHERENCE; NONHUMAN; PARAINFLUENZA VIRUS 1; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; BINDING SITES; CELL ADHESION; GENE THERAPY; INTERLEUKIN-8; MYOCARDIAL REPERFUSION INJURY; NEUTROPHILS; NF-KAPPA B; OLIGONUCLEOTIDES; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION;

EID: 0343765716     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Billups KL, Palladino MA, Hinton BT, Sherley JL. Expression of E-selectin mRNA during ischemia/reperfusion injury. J Lab Clin Med. 1995;125:626-633.
2. Kukielka GL, et al. Induction of interleukin-6 synthesis in the myocardium: potential role in postreperfusion inflammatory injury. Circulation. 1995;92:1866-1875.
3. Oz MC, et al. Ischemia-induced interleukin 8 release after human heart transplantation: a potential role for endothelial cells. Circulation. 1995;92:II-428-II-432.
4. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol. 1995;146:419-428.
5. Sawa Y, Taniguchi K, Kadoba K, Nishimura M, Ichikawa H, Amemiya A, Kuratani T, Matsuda H. Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy. Circulation. 1996;93:1640-1646.
6. Lenardo MJ, Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell. 1989;58:227-229.
7. Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol. 1990;10:2327-2334.
8. Satriano J, Schlondorff. Activation and attenuation of transcription factor NF-kB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3′:5′-cyclic monophosphate: evidence for involvement of reactive oxygen species. J Clin Invest. 1994;94:1629-1636.
9. Brennan DC, Jevnikar AM, Takei F, Reubin-Kelley VE. Mesangial cell accessory functions: mediation by intercellular adhesion molecule-1. Kidney Int. 1990;38:1039-1046.
10. Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med. 1992;176:1583-1593.
11. Yamazaki T, et al. Expression of intercellular adhesion molecule-1 in rat heart with ischemia/reperfusion and limitation of infarct size by treatment with antibodies against cell adhesion molecules. Am J Pathol. 1993;143:410-418.
12. Sullenger BA, Gallardo HF, Ungers GE, Gilboa E. Overexpression of TAR sequence renders cells resistant to human immunodeficiency virus replication. Cell. 1990;63:601-608.
13. Bielinska A, Schivdasani RA, Zhang L, Nabel GJ. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science. 1990;250:997-100.
14. Yamada T, et al. In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer. J Clin Invest. 1995;96:1230-1237.
15. Morishita R, et al. Role of transcriptional cis-elements, angiotensinogen gene-activating element, of angiotensinogen gene in blood pressure regulation. Hypertension. 1996;27:502-507.
16. Morishita R, et al. A novel molecular strategy using cis element 'decoy' of E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci USA. 1995;92:5855-5859.
17. Sawa Y, Suzuki K, Bai HZ, Shirakura R, Morishita R, Kaneda Y, Matsuda H. Efficiency of in vivo gene transfection into transplanted rat heart by coronary infusion of HVJ liposome. Circulation. 1995; 92:11-479-11-482.
18. Kaneda Y, Iwai K, Uchida T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science. 1989;243: 375-378.
19. Sawa Y, et al. Myocardial protective effect and its mechanism of leukocyte-depleted reperfusion in neonatal rabbit hearts. Ann Thorac Surg. 1994;58:1386-1391.
20. Morishita R, et al. Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth. J Clin Invest. 1994;94:824-829.
21. Morishita R, Sugimoto T, Aoki M, Tomita N, Moriguchi A, Kida I, Maeda K, Sawa Y, Kaneda Y, Higaki J, Ogihara T. In vivo transfection of cis 'decoy' against NFkB binding site prevented myocardial infarction as a gene therapy. Circulation. 1996;94:I-225.
22. Sawa Y, Shimazaki Y, Kadoba K, Masai T, Fukuda H, Ohata T, Taniguchi K, Matsuda H. Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardialreperfusion injury in open heart surgery. J Thorac Cardiovasc Surg. 1996;111: 29-35.
23. Sawa Y, Matsuda H, Shimazaki Y, Kaneko M, Nishimura M, Amemiya A, Sakai K, Nakano S. Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1994;108:1125-1131.
24. Sobel BE, Bresnahan GF, Shell WE, Yoder RD. Estimation of infarct size in man and its relation to prognosis. Circulation. 1972; 106:640-648.